{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T21:44:20Z","timestamp":1792532660275,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T00:00:00Z","timestamp":1688428800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T00:00:00Z","timestamp":1688428800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1007\/s10067-023-06686-6","type":"journal-article","created":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T22:01:45Z","timestamp":1688508105000},"page":"3021-3031","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Risk factors for cardiovascular disease in primary Sj\u00f6gren\u2019s syndrome (pSS): a 20-year follow-up study"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0889-9877","authenticated-orcid":false,"given":"Cristiana Sieiro","family":"Santos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben Rego","family":"Salgueiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara Moriano","family":"Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina \u00c1lvarez","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvira D\u00edez","family":"\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,4]]},"reference":[{"issue":"10","key":"6686_CR1","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1056\/NEJMcp1702514","volume":"378","author":"X Mariette","year":"2018","unstructured":"Mariette X, Criswell LA (2018) Primary Sjogren\u2019s syndrome. N Engl J Med 378(10):931\u2013939","journal-title":"N Engl J Med"},{"key":"6686_CR2","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1136\/ard.2004.025676","volume":"64","author":"M Ramos-Casals","year":"2005","unstructured":"Ramos-Casals M, Tzioufas AG, Font J (2005) Primary Sjogren\u2019s syndrome: new clinical and therapeutic concepts. Ann Rheum Dis 64:347\u2013354","journal-title":"Ann Rheum Dis"},{"key":"6686_CR3","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3109\/08916930903374527","volume":"43","author":"Y Sherer","year":"2010","unstructured":"Sherer Y, Zinger H, Shoenfeld Y (2010) Atherosclerosis in systemic lupus erythematosus. Autoimmunity 43:98\u2013102","journal-title":"Autoimmunity"},{"key":"6686_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/qjmed\/94.1.19","volume":"94","author":"J Font","year":"2001","unstructured":"Font J, Ramos-Casals M, Cervera R et al (2001) Cardiovascular risk factors and the long-term outcome of lupus nephritis. QJM 94:19\u201326","journal-title":"QJM"},{"issue":"3","key":"6686_CR5","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1177\/09612033221147471","volume":"32","author":"N Bello","year":"2023","unstructured":"Bello N, Meyers KJ, Workman J, Hartley L, McMahon M (2023) Cardiovascular events and risk in patients with systemic lupus erythematosus: Systematic literature review and meta-analysis. Lupus 32(3):325\u2013341","journal-title":"Lupus"},{"key":"6686_CR6","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.semarthrit.2005.03.004","volume":"35","author":"MA Gonzalez-Gay","year":"2005","unstructured":"Gonzalez-Gay MA, Gonzalez-Juanatey C, Martin J (2005) Rheumatoid arthritis: a disease associated with accelerated atherogenesis. Semin Arthritis Rheum 35:8\u201317","journal-title":"Semin Arthritis Rheum"},{"key":"6686_CR7","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/acr.20322","volume":"63","author":"E Bartoloni","year":"2011","unstructured":"Bartoloni E, Shoenfeld Y, Gerli R (2011) Inflammatory and autoimmune mechanisms in the induction of atherosclerotic damage in systemic rheumatic diseases: two faces of the same coin. Arthritis Care Res 63:178\u2013183","journal-title":"Arthritis Care Res"},{"key":"6686_CR8","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1136\/annrheumdis-2013-204024","volume":"74","author":"EE Arts","year":"2015","unstructured":"Arts EE, Popa C, Den Broeder AA et al (2015) Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis. Ann Rheum Dis 74:668\u2013674","journal-title":"Ann Rheum Dis"},{"issue":"Suppl.112","key":"6686_CR9","first-page":"S190","volume":"36","author":"WC Yong","year":"2018","unstructured":"Yong WC, Sanguankeo A (2018) Upala: Association between primary Sj\u00f6gren\u2019s syndrome, cardiovascular and cerebrovascular disease: a systematic review and meta-analysis. Clin Exp Rheumatol 36(Suppl.112):S190\u2013S197","journal-title":"Clin Exp Rheumatol"},{"key":"6686_CR10","doi-asserted-by":"publisher","first-page":"3890","DOI":"10.1002\/art.21475","volume":"52","author":"G Vaudo","year":"2005","unstructured":"Vaudo G, Bocci EB, Shoenfeld Y et al (2005) Precocious intima-media thickening in patients with primary Sjogren\u2019s syndrome. Arthritis Rheum 52:3890\u20133897","journal-title":"Arthritis Rheum"},{"issue":"4","key":"6686_CR11","first-page":"754","volume":"34","author":"M Ramos-Casals","year":"2007","unstructured":"Ramos-Casals M, Brito-Zer\u00f3n P, Sis\u00f3 A, Vargas A, Ros E, Bove A, Belenguer R, Plaza J, Benavent J, Font J (2007) High prevalence of serum metabolic alterations in primary Sj\u00f6gren\u2019s syndrome: influence on clinical and immunological expression. J Rheumatol 34(4):754\u2013761","journal-title":"J Rheumatol"},{"key":"6686_CR12","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/joim.12941","volume":"286","author":"J Mofors","year":"2019","unstructured":"Mofors J, Holmqvist M, Westermark L et al (2019) Concomitant Ro\/ SSA and La\/SSB antibodies are biomarkers for the risk of venous thromboembolism and cerebral infarction in primary Sjogren\u2019s syndrome. J Intern Med 286:458\u2013468","journal-title":"J Intern Med"},{"issue":"6","key":"6686_CR13","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH (2002 Jun) European Study Group on Classification Criteria for Sj\u00f6gren\u2019s Syndrome. Classification criteria for Sj\u00f6gren\u2019s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61(6):554\u2013558","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"6686_CR14","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1136\/ard.2009.110619","volume":"69","author":"R Seror","year":"2010","unstructured":"Seror R, Ravaud P, Bowman SJ, Baron G, Tzioufas A, Theander E, Gottenberg JE, Bootsma H, Mariette X, Vitali C, EULAR Sj\u00f6gren\u2019s Task Force (2010) EULAR Sjogren\u2019s syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren\u2019s syndrome. Ann Rheum Dis 69(6):1103\u20131109","journal-title":"Ann Rheum Dis"},{"key":"6686_CR15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.coms.2013.09.005","volume":"26","author":"K Delli","year":"2014","unstructured":"Delli K, Vissink A, Spijkervet FK (2014) Salivary gland biopsy for Sjogren\u2019s syndrome. Oral Maxillofac Surg Clin North Am 26:23\u201333","journal-title":"Oral Maxillofac Surg Clin North Am"},{"issue":"Suppl 126","key":"6686_CR16","first-page":"10","volume":"38","author":"V Manfr\u00e8","year":"2020","unstructured":"Manfr\u00e8 V, Cafaro G, Riccucci I, Zabotti A, Perricone C, Bootsma H et al (2020) One Year in Review 2020: Comorbidities, Diagnosis and Treatment of Primary Sj\u00f6gren\u2019s Syndrome. Clin Exp Rheumatol 38(Suppl 126):10\u201322","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"6686_CR17","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/joim.12346","volume":"278","author":"E Bartoloni","year":"2015","unstructured":"Bartoloni E, Baldini C, Schillaci G, Quartuccio L, Priori R, Carubbi F et al (2015) Cardiovascular Disease Risk Burden in Primary Sj\u00f6gren\u2019s Syndrome: Results of a Population-Based Multicentre Cohort Study. J Intern Med 278(2):185\u2013192","journal-title":"J Intern Med"},{"issue":"1","key":"6686_CR18","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/acr.23821","volume":"72","author":"A Beltai","year":"2020","unstructured":"Beltai A, Barnetche T, Daien C, Lukas C, Gaujoux-Viala C, Combe B et al (2020) Cardiovascular Morbidity and Mortality in Primary Sj\u00f6gren\u2019s Syndrome: A Systematic Review and Meta-Analysis. Arthritis Care Res 72(1):131\u2013139","journal-title":"Arthritis Care Res"},{"issue":"5","key":"6686_CR19","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1002\/acr.22227","volume":"66","author":"M Juarez","year":"2014","unstructured":"Juarez M, Toms TE, de Pablo P, Mitchell S, Bowman S, Nightingale P et al (2014) Cardiovascular Risk Factors in Women With Primary Sj\u00f6gren\u2019s Syndrome: United Kingdom Primary Sj\u00f6gren\u2019s Syndrome Registry Results. Arthritis Care Res 66(5):757\u2013764","journal-title":"Arthritis Care Res"},{"issue":"3","key":"6686_CR20","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s10067-015-3072-1","volume":"35","author":"KL Augusto","year":"2016","unstructured":"Augusto KL, Bonfa E, Pereira RMR, Bueno C, Leon EP, Viana VST et al (2016) Metabolic Syndrome in Sj\u00f6gren\u2019s Syndrome Patients: A Relevant Concern for Clinical Monitoring. Clin Rheumatol 35(3):639\u2013647","journal-title":"Clin Rheumatol"},{"issue":"4","key":"6686_CR21","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.21037\/jtd.2018.03.120","volume":"10","author":"Y Wang","year":"2018","unstructured":"Wang Y, Hou Z, Qiu M et al (2018) Risk factors for primary Sjogren syndrome-associated interstitial lung disease. J Thorac Dis 10(4):2108\u20132117","journal-title":"J Thorac Dis"},{"key":"6686_CR22","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1002\/acr.22227","volume":"5","author":"M Juarez","year":"2014","unstructured":"Juarez M, Toms TE, De Pablo P et al (2014) Cardiovascular risk factors in women with primary Sj\u00f6gren\u2019s syndrome: United Kingdom primary Sj\u00f6gren\u2019s syndrome registry results. Arthritis Care Res 5:757\u2013764","journal-title":"Arthritis Care Res"},{"key":"6686_CR23","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1177\/0961203310367504","volume":"19","author":"M P\u00e9rez-De-Lis","year":"2010","unstructured":"P\u00e9rez-De-Lis M, Akasbi M, Sis\u00f3 A, Diez-Cascon P, Brito-Zer\u00f3n P, Diaz-Lagares C, Ortiz J, Perez-Alvarez R, Ramos-Casals M, Coca A (2010) Cardiovascular risk factors in primary Sj\u00f6gren\u2019s syndrome: a case-control study in 624 patients. Lupus 19:941\u2013948","journal-title":"Lupus"},{"key":"6686_CR24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nrcardio.2017.118","volume":"15","author":"E Bartoloni","year":"2018","unstructured":"Bartoloni E, Alunno A, Gerli R (2018) Hypertension as a cardiovascular risk factor in autoimmune rheumatic diseases. Nat Rev Cardiol 15:33\u201344","journal-title":"Nat Rev Cardiol"},{"key":"6686_CR25","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13075-015-0613-6","volume":"17","author":"F Gravani","year":"2015","unstructured":"Gravani F, Papadaki I, Antypa E et al (2015) Subclinical atherosclerosis and impaired bone health in patients with primary Sj\u00f6gren\u2019s syndrome: prevalence, clinical and laboratory associations. Arthritis Res Ther 17:99","journal-title":"Arthritis Res Ther"},{"key":"6686_CR26","first-page":"1006","volume":"34","author":"GM Balarini","year":"2016","unstructured":"Balarini GM, Zandonade E, Tanure L et al (2016) Serum calprotectin is a biomarker of carotid atherosclerosis in patients with primary Sj\u00f6gren\u2019s syndrome. Clin Exp Rheum 34:1006\u20131012","journal-title":"Clin Exp Rheum"},{"issue":"8","key":"6686_CR27","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.3899\/jrheum.170029","volume":"44","author":"S Gunter","year":"2017","unstructured":"Gunter S, Robinson C, Norton GR, Woodiwiss AJ, Tsang L, Dessein PH, Millen AME (2017) Cardiovascular Risk Factors and Disease Characteristics Are Consistently Associated with Arterial Function in Rheumatoid Arthritis. J Rheumatol 44(8):1125\u20131133","journal-title":"J Rheumatol"},{"key":"6686_CR28","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1093\/rheumatology\/kei190","volume":"45","author":"BM Lodde","year":"2006","unstructured":"Lodde BM, Sankar V, Kok MR, Leakan RA, Tak PP, Pillemer SR (2006) Serum lipid levels in Sj\u00f6gren\u2019s syndrome. Rheumatology 45:481\u2013484","journal-title":"Rheumatology"},{"key":"6686_CR29","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jbspin.2010.02.011","volume":"77","author":"W Cruz","year":"2010","unstructured":"Cruz W, Fialho S, Morato E et al (2010) Is there a link between inflammation and abnormal lipoprotein profile in Sj\u00f6gren\u2019s syndrome? Joint Bone Spine 77:229\u2013231","journal-title":"Joint Bone Spine"},{"key":"6686_CR30","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1093\/rheumatology\/28.6.518","volume":"28","author":"A Binder","year":"1989","unstructured":"Binder A, Maddison PJ, Skinner P, Kurtz A, Isenberg DA (1989) Sj\u00f6gren\u2019s syndrome: association with type-1 diabetes mellitus. Br J Rheumatol 28:518\u2013520","journal-title":"Br J Rheumatol"},{"issue":"8","key":"6686_CR31","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1111\/jch.14541","volume":"24","author":"Q Luo","year":"2022","unstructured":"Luo Q, Qin L, Zhang Y, Yang X, Wang H (2022) Relationship between serum uric acid and hypertension in patients with primary Sj\u00f6gren\u2019s syndrome: A retrospective cohort study. J Clin Hypertens (Greenwich) 24(8):1026\u20131034","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"6686_CR32","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1136\/annrheumdis-2022-eular.3603","volume":"81","author":"A Alunno","year":"2022","unstructured":"Alunno A, Carubbi F, Mariani FM et al (2022) AB0524 Relationship between serum acid, cardiovascular risk and inflammatory status in Primary Sjogren\u2019s syndrome. Ann Rheum Dis 81:1390","journal-title":"Ann Rheum Dis"},{"key":"6686_CR33","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/joim.12941","volume":"286","author":"J Mofors","year":"2019","unstructured":"Mofors J, Holmqvist M, Westermark L, Bj\u00f6rk A, Kvarnstr\u00f6m M, Forsbladd\u2019Elia H et al (2019) Concomitant Ro\/SSA and La\/SSB antibodies are biomarkers for the risk of venous thromboembolism and cerebral infarction in primary Sj\u00f6gren\u2019s syndrome. J Intern Med 286:458\u2013468","journal-title":"J Intern Med"},{"issue":"140","key":"6686_CR34","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1183\/16000617.0011-2016","volume":"25","author":"T Flament","year":"2016","unstructured":"Flament T, Bigot A, Chaigne B, Henique H, Diot E, Marchand-Adam S (2016) Pulmonary Manifestations of Sj\u00f6gren\u2019s Syndrome. Eur Respir Rev 25(140):110\u2013123","journal-title":"Eur Respir Rev"},{"key":"6686_CR35","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/B978-0-323-67534-5.00006-5","volume-title":"Sjogren\u2019s Syndrome: A Clinical Handbook 1st Edition - October 13, 2019","author":"CR Johr","year":"2020","unstructured":"Johr CR (2020) Chapter 6 - Extraglandular Abnormalities in Sj\u00f6gren\u2019s Syndrome. In: Vivino FB (ed) Sjogren\u2019s Syndrome: A Clinical Handbook 1st Edition - October 13, 2019. Elsevier, Sjogren\u2019s Syndrome, pp 93\u2013115"},{"issue":"47","key":"6686_CR36","doi-asserted-by":"publisher","first-page":"4912","DOI":"10.1093\/eurheartj\/ehac516","volume":"43","author":"A Akuka","year":"2022","unstructured":"Akuka A, Ben-Shabat N, Watad A (2022) Avishai M Tsur, Scott Ehrenberg, Dennis McGonagle, Doron Comaneshter, Roy Beinart, Arnon D Cohen, Howard Amital, Association of anti-Ro seropositivity with cardiac rhythm and conduction disturbances. Eur Heart J 43(47):4912\u20134919","journal-title":"Eur Heart J"},{"issue":"8","key":"6686_CR37","doi-asserted-by":"publisher","first-page":"730161","DOI":"10.3389\/fmed.2021.730161","volume":"6","author":"PE Lazzerini","year":"2021","unstructured":"Lazzerini PE, Laghi-Pasini F, Boutjdir M, Capecchi PL (2021) Anti-Ro\/SSA Antibodies and the Autoimmune Long-QT Syndrome. Front Med (Lausanne) 6(8):730161","journal-title":"Front Med (Lausanne)"},{"key":"6686_CR38","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1177\/0961203306071872","volume":"15","author":"G Ruiz-Irastorza","year":"2006","unstructured":"Ruiz-Irastorza G, Egurbide MV, Pijoan JI et al (2006) Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus. Lupus 15:577\u2013583","journal-title":"Lupus"},{"key":"6686_CR39","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1136\/ard.2008.101766","volume":"69","author":"G Ruiz-Irastorza","year":"2010","unstructured":"Ruiz-Irastorza G, Ramos-Casals M, Brito-Zeron P, Khamashta MA (2010) Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review. Ann Rheum Dis 69:20\u201328","journal-title":"Ann Rheum Dis"},{"key":"6686_CR40","doi-asserted-by":"publisher","first-page":"5767","DOI":"10.1073\/pnas.94.11.5767","volume":"94","author":"CP Robinson","year":"1997","unstructured":"Robinson CP, Yamachika S, Alford CE et al (1997) Elevated levels of cysteine protease activity in saliva and salivary glands of the nonobese diabetic (NOD) mouse model for Sjogren syndrome. Proc Natl Acad Sci U S A 94:5767\u20135771","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"6686_CR41","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1002\/art.39537","volume":"68","author":"M Movahedi","year":"2016","unstructured":"Movahedi M, Beauchamp ME, Abrahamowicz M, Ray DW, Michaud K, Pedro S et al (2016) Risk of Incident Diabetes Mellitus Associated With the Dosage and Duration of Oral Glucocorticoid Therapy in Patients With Rheumatoid Arthritis. Arthritis Rheumatol 68(5):1089\u20131098","journal-title":"Arthritis Rheumatol"},{"issue":"25","key":"6686_CR42","doi-asserted-by":"publisher","first-page":"E680","DOI":"10.1503\/cmaj.190178","volume":"191","author":"J Wu","year":"2019","unstructured":"Wu J, Keeley A, Mallen C, Morgan AW, Pujades-Rodriguez M (2019) Incidence of infections associated with oral glucocorticoid dose in people diagnosed with polymyalgia rheumatica or giant cell arteritis: a cohort study in England. CMAJ 191(25):E680\u2013E688","journal-title":"CMAJ"},{"issue":"12","key":"6686_CR43","doi-asserted-by":"publisher","first-page":"E295","DOI":"10.1503\/cmaj.191012","volume":"192","author":"TF Mebrahtu","year":"2020","unstructured":"Mebrahtu TF, Morgan AW, West RM, Stewart PM, Pujades-Rodriguez M (2020) Oral glucocorticoids and incidence of hypertension in people with chronic inflammatory diseases: a population-based cohort study. CMAJ 192(12):E295\u2013E301","journal-title":"CMAJ"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06686-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-023-06686-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06686-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T10:11:50Z","timestamp":1697710310000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-023-06686-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,4]]},"references-count":43,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["6686"],"URL":"https:\/\/doi.org\/10.1007\/s10067-023-06686-6","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,4]]},"assertion":[{"value":"1 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This study was approved by Complejo Asistencial Universitario de Le\u00f3n\u2019s Ethical Committee. Participants gave written consent to participate in the study before taking part.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}